2021 Revenues ($USD) : $206,531,000
2021 R&D spend : $43,070,000
2021 Number of Employees : 750
Fiscal Year End : 12/31/2020
Key People : Michael Carrel, president and CEO; Angela Wirick, CFO; Douglas Seith, COO; Justin Noznesky, chief marketing and strategy officer; Karl Dahlquist, chief legal officer; Salvatore Privitera, CTO; Vinayak Doraiswamy, chief scientific officer; Tonya Austin, chief human resources officer.

About the company: AtriCure is developing technologies to treat atrial fibrillation and other related conditions. Founded in 1994 as Enable Medical, the Cincinnati-area company has numerous ablation systems on the market, as well as its AtriClip left atrial appendage exclusion system. AtriCure has served over 375,000 ablation patients since its founding and has sold more than 300,000 AtriClip devices. –DK